Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;28(12):1199-203.
doi: 10.1007/s00268-004-7604-0. Epub 2004 Nov 11.

Modified radical neck dissection for differentiated thyroid cancer: operative technique

Affiliations

Modified radical neck dissection for differentiated thyroid cancer: operative technique

Shinya Uchino et al. World J Surg. 2004 Dec.

Abstract

Our standard surgical approach to patients with papillary thyroid cancer is subtotal thyroidectomy with modified radical neck dissection (MRND) on the affected side. MRND preserves the jugular vein, the sternocleidomastoid muscle, and the accessory nerve, effectively conserving function and cosmesis. Knowledge of the anatomy of the neck, precise staging, prognostic evaluation, and experience are needed for a surgeon to perform MRND. Radical neck dissection should not be performed unless the tumor invades the jugular vein and sternocleidomastoid muscle. Berry picking is not indicated for patients with thyroid cancer. The skin incision used is an extended collar incision. If lymph node metastasis is present at the upper bifurcation of the carotid artery, a modified MacFee incision is used. Taping of the carotid artery or sternocleidomastoid muscle is avoided unless the tumor invades these tissues. MRND is a safe procedure when performed by skilled, experienced surgeons.

PubMed Disclaimer

References

    1. Surg Oncol Clin N Am. 1996 Jan;5(1):43-63 - PubMed
    1. Cancer. 1970 Nov;26(5):1061-4 - PubMed
    1. Eur J Surg. 1998 Dec;164(12):927-33 - PubMed
    1. Surg Clin North Am. 1987 Apr;67(2):251-61 - PubMed
    1. Eur J Cancer Clin Oncol. 1988 Feb;24(2):315-24 - PubMed

LinkOut - more resources